Search results for "small intestinal bacterial overgrowth."

showing 4 items of 4 documents

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

2009

AIM: To estimate the prevalence of small intestinal bacterial overgrowth (SIBO) in our geographical area (Western Sicily, Italy) by means of an observational study, and to gather information on the use of locally active, non-absorbable antibiotics for treatment of SIBO. METHODS: Our survey included 115 patients fulfilling the Rome II criteria for diagnosis of irritable bowel syndrome (IBS); a total of 97 patients accepted to perform a breath test with lactulose (BTLact), and those who had a positive test, received Rifaximin (Normix®, Alfa Wassermann) 1200 mg/d for 7 d; 3 wk after the end of treatment, the BTLact was repeated. RESULTS: Based on the BTLact results, SIBO was present in about 5…

AdultMalemedicine.medical_specialtyConstipationGastroenterologyRifaximinIrritable Bowel SyndromeLactulosechemistry.chemical_compoundAnti-Infective AgentsGastrointestinal AgentsInternal medicineIntestine SmallSmall intestinal bacterial overgrowthmedicineHumansSicilyIrritable bowel syndromeBreath testSettore MED/12 - GastroenterologiaGastrointestinal agentmedicine.diagnostic_testbusiness.industrydigestive oral and skin physiologyGastroenterologyBacterial InfectionsGeneral Medicinemedicine.diseaseRifamycinsLactuloseRifaximinBrief ArticlesBreath TestschemistryEtiologyFemalemedicine.symptombusinessSIBO rifaximinemedicine.drugWorld Journal of Gastroenterology
researchProduct

From Food Map to FODMAP in Irritable Bowel Sindrome.

2016

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diseases in the general population, with a prevalence ranging from 12 % to 30 %, mainly affecting younger patients (i.e., <50 years of age) and women [1]. As in other chronic functional gastrointestinal disorders, abdominal discomfort or pain, abnormal bowel habits, and often bloating and abdominal distension are the main clinical features. Their diagnosis is based on symptom patterns (i.e., the Rome III criteria), which also allow categorization in diarrhea-predominant (D-IBS), constipation-predominant (C-IBS), mixed diarrhea and constipation (M-IBS), and unclassified (U-IBS) IBS [2]. Symptom severity ranges from tol…

chemistry.chemical_classificationmedicine.medical_specialtyeducation.field_of_studyConstipationSettore MED/09 - Medicina Internabusiness.industryPopulationIrritable Bowel Sindrome.FODMAPAbdominal distensionmedicine.diseaseFODMAP; Irritable Bowel Sindrome.DiarrheaBloatingchemistryInternal medicineSmall intestinal bacterial overgrowthmedicinemedicine.symptomeducationbusinessFODMAPIrritable bowel syndrome
researchProduct

Clinical case and short review of extreme short bowel syndrome: an update 21 years after

2016

Short bowel syndrome refers to the malabsorptive state caused by loss of significant portions of the small intestine, whose clinical framework is characterized by malnutrition, diarrhea, dehydration, weight loss, and low-weight-related symptoms/signs. These clinical conditions seem to be related to the length of resection. Twenty-one years ago we reported the clinical case of an infant, who underwent a massive resection of the loops of the small intestine, of the cecum and of part of the ascending colon, due to intestinal malrotation with volvulus. The residual small intestine measured just 11 cm and consisted of the duodenum and a small part of jejunum, in the absence of the ileocecal valv…

medicine.medical_specialtySettore MED/09 - Medicina InternaMalabsorptionmalabsorptionlcsh:MedicinemalnutritionGastroenterologyJejunum03 medical and health sciencesIleocecal valve0302 clinical medicineInternal medicineSmall intestinal bacterial overgrowthmedicinesmall intestinal bacterial overgrowth.Ascending colon030212 general & internal medicinebusiness.industryShort bowel syndromelcsh:RGeneral Medicinemedicine.diseaseShort bowel syndromeVolvulusSurgerymedicine.anatomical_structureIntestinal malrotation030211 gastroenterology & hepatologybusinessUltra-short bowel syndromeItalian Journal of Medicine
researchProduct

Hydrogen- and Methane-Based Breath Testing and Outcomes in Patients With Heart Failure

2019

Background: Recent evidence endorses gut microbiota dysregulation in the pathophysiology of heart failure (HF). Small intestinal bacterial overgrowth (SIBO) might be present in HF and associated with poor clinical outcomes. Lactulose breath testing is a simple noninvasive test that has been advocated as a reliable indicator of SIBO. In patients with HF, we aimed to evaluate the association with clinical outcomes of the exhaled hydrogen (H-2) and methane (CH4) concentrations through the lactulose breath test. Methods and Results: We included 102 patients with HF in which lactulose SIBO breath tests were assessed. Cumulative gas was quantified by the area under the receiver operating characte…

Malemedicine.medical_specialtyheart failuresmall intestinal bacterial overgrowth030204 cardiovascular system & hematologyRate ratioGastroenterologyArticle03 medical and health sciencesLactulose0302 clinical medicineInterquartile rangeInternal medicineIntestine SmallSmall intestinal bacterial overgrowthmedicineHumansGutProspective Studies030212 general & internal medicineAgedAged 80 and overHeart FailureBreath testBacteriamedicine.diagnostic_testReceiver operating characteristicbusiness.industryHazard ratiomedicine.diseaseGastrointestinal MicrobiomeHospitalizationBreath TestsExhalationHeart failureFemalebreath testsprognosisCardiology and Cardiovascular MedicinebusinessMethaneFollow-Up StudiesHydrogenmedicine.drug
researchProduct